Federation

Type 1 diabetes researchers from across Canada sign letter of support for diabetes research to be included in the upcoming federal budget

Retrieved on: 
Monday, March 25, 2024
B cell, Letter, Science, Federation, Diabetes, Immunosuppression, Patient, Research, Investment, JDRF, Safety, Federal, CIHR, Pharmaceutical industry

TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes through Federal Budget 2024.

Key Points: 
  • TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes through Federal Budget 2024.
  • The letter details the importance of funding research in the field of islet replacement therapy, of which Canada is a global leader.
  • As Canadian researchers working in the field of islet replacement therapy for diabetes, we write this letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes through Federal Budget 2024.
  • Type 1 diabetes (T1D) is an autoimmune condition resulting in absolute insulin deficiency, for which there is no available cure.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Palo Alto Networks, Inc. - PANW

Retrieved on: 
Saturday, March 23, 2024
Prior, Palo Alto Networks, Federation, News, Ext, Complaint, Pomerantz, Action Replay, Court

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Palo Alto Networks, Inc. (“Palo Alto Networks” or the “Company”) (NASDAQ: PANW).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Palo Alto Networks, Inc. (“Palo Alto Networks” or the “Company”) (NASDAQ: PANW).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Palo Alto Networks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Innodata, Fox Factory, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, March 22, 2024
Research, Class Action, Growth, Palo Alto Networks, Intelligence, Federation, EPS, Internet of things, PANW, Defendant, Internet, News, Transport, AI, Nature, Complaint, Silicon, City, P.C, Goldengate, Research and development, Fox Factory, Wolfpack, Marketing

Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.

Key Points: 
  • Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.
  • On this news, the price of Innodata common stock declined by $3.74 per share, or approximately 30.5%, on February 15, 2024.
  • The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
  • For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

SAI.TECH Announces Expansion of SAI NODE Marietta, Increases Hash Rate by 68PH/s

Retrieved on: 
Thursday, March 21, 2024
Immersion, Recycling, Federation, Miner, ACCE, Weather, Cryptocurrency

This expansion demonstrates the company's dedication to enhancing the SAI NODE Marietta1, the Company’s US R&D center that focused on advancing technology for high-performance computing liquid cooling and industrial-scale computing heat recycling.

Key Points: 
  • This expansion demonstrates the company's dedication to enhancing the SAI NODE Marietta1, the Company’s US R&D center that focused on advancing technology for high-performance computing liquid cooling and industrial-scale computing heat recycling.
  • The expansion involves the strategic addition of 190 units of Bitmain S19 Pro+ Hydro bitcoin mining machines and 288 units of Bitmain S19 K Pro bitcoin mining machines.
  • The deployment of the 478 bitcoin mining machines and the underlying investment of approximately $0.9 million increased the hash rate capacity of SAI NODE Marietta by approximately 68 PH/s (petahash per second).
  • Along with this expansion, SAI.TECH also announced an update about the SAI NODE Marietta as part of its ongoing efforts to provide sustainable and energy-efficient solutions to the bitcoin mining industry.

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 21, 2024
Research, MPV, IIM, MuSK protein, Toxicity, Conference, Disease, Dermatomyositis, Juvenile dermatomyositis, Federation, Patient, NOL, Observation, CRS, SLE, Health Canada, IND, Immunoglobulin therapy, Pemphigus, Investment, Investigational New Drug, Myopathy, Systemic scleroderma, Marketing, FDA, Clinical trial, Cytokine release syndrome, Cyclophosphamide, CD19, Food, Autoimmune disease, Pharmaceutical industry

In October 2023, Cabaletta received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA) for the Phase 1/2 RESET-SSc trial.

Key Points: 
  • In October 2023, Cabaletta received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA) for the Phase 1/2 RESET-SSc trial.
  • In November 2023, Cabaletta announced that its IND application for CABA-201 was allowed to proceed by the FDA for the Phase 1/2 RESET-MG trial.
  • Cabaletta anticipates reporting initial clinical data from the Phase 1/2 RESET-MG trial in the second half of 2024.
  • As of December 31, 2023, Cabaletta had cash, cash equivalents and short-term investments of $241.2 million, compared to $106.5 million as of December 31, 2022.

Medicaid unwinding approaches one-year mark: Disenrolled count surpasses initial expectations, continues to climb

Retrieved on: 
Thursday, March 21, 2024
Family, Federation, Health, COVID-19, Public, Kaiser, Knowledge, Policy, Human services, Health policy, Marketplace, ACA, Health insurance

The U.S. Department of Health & Human Services initially projected up to 15 million people would lose Medicaid or Children’s Health Insurance Program coverage.

Key Points: 
  • The U.S. Department of Health & Human Services initially projected up to 15 million people would lose Medicaid or Children’s Health Insurance Program coverage.
  • Since the beginning of Medicaid unwinding on April 1, 2023, Medicaid has been renewed for almost 40 million beneficiaries.
  • A significant majority of Medicaid disenrollments were procedural disenrollments, meaning enrollees did not complete the required renewal process to keep their Medicaid coverage.
  • As Medicaid unwinding continues, Medicaid enrollees may continue to receive communications and requests from their state or county Medicaid offices requesting information to help determine their Medicaid eligibility.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Palo Alto Networks, Inc. (PANW)

Retrieved on: 
Thursday, March 21, 2024
Federation, PANW, GPM, Defendant, News, Suite, Court, Cryptocurrency

On February 20, 2024, Palo Alto released its second quarter fiscal 2024 financial results and lowered its full year revenue and billing guidance.

Key Points: 
  • On February 20, 2024, Palo Alto released its second quarter fiscal 2024 financial results and lowered its full year revenue and billing guidance.
  • On this news, Palo Alto’s stock price fell $104.12, or 28.4%, to close at $261.97 per share on February 21, 2024, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Castellum, Inc. Announces 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
GAAP, Federation, Form 10-K, CTM, Security (finance), Cryptocurrency

BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.

Key Points: 
  • BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.
  • It is expected that audited financial results for 2023 will be disclosed in its Form 10-K which the Company expects to file with the Securities and Exchange Commission at www.sec.gov after the market closes today.
  • Management uses a Non-GAAP financial measure, Recurring Cash Operating Profit (“RCOP”), as an important measure of the Company’s operating performance.
  • See below for a full reconciliation of GAAP operating loss with non-GAAP recurring cash operating profit for Q4 2023.

Rep. Jim McGovern Shines Light on Chinese Smithfield’s Attempt to Overturn State Laws Including Massachusetts' Question 3

Retrieved on: 
Wednesday, March 20, 2024
Communist party, Congress, Republican, 2018 California Proposition 12, Face, Letter, Smithfield Foods, Hoxhaism, D-MI, House Committee, Niman Ranch, Agriculture, R-PA, Federation, Ranking, CMA, R-AR, Committee, Farmer, CCP, Sale, Policy, House, Organization, Competition (economics), Heritage Foods, Question 3, Freedom Caucus, HFC, For America, Government, FreedomWorks, Senate, Legislation, OCM

Both measures prohibit the sale of certain types of factory farmed pork products in these states.

Key Points: 
  • Both measures prohibit the sale of certain types of factory farmed pork products in these states.
  • “We applaud Rep. McGovern for shining light on Smithfield’s infiltration of American agriculture and the multinational conglomerate’s efforts to overturn state laws like Massachusetts’ Question 3,” said Marty Irby, president and CEO at Competitive Markets Action and board secretary at the Organization for Competitive Markets.
  • To date, 226 bipartisan Members of Congress, including McGovern, have vocalized their opposition to the nullification of Question 3 and Prop 12.
  • 171 bipartisan Members of the House sent a letter to Thompson and Scott in August of 2023 and 31 U.S.

U.S House Hearing on Chinese Infiltration of American Agriculture Set for 11:30 AM Today

Retrieved on: 
Wednesday, March 20, 2024
Letter, MFA, Face, Ranking, Hearing, CCP, Lobbying, FreedomWorks, Legislation, Assault, Mother, Congress, 2018 California Proposition 12, Policy, Woman, Competition (economics), HFC, Virtue, Senate, OCM, Communist party, Federation, R-AR, CMA, Human, House, Heritage Foods, Freedom Caucus, Family, For America, USDA, Farmer, Smithfield Foods, Hoxhaism, D-MI, House Committee, Niman Ranch, Organization, Government

The hearing, entitled “The Danger China Poses to American Agriculture,” is set to be held at 11:30 AM EST.

Key Points: 
  • The hearing, entitled “The Danger China Poses to American Agriculture,” is set to be held at 11:30 AM EST.
  • The groups call comes in the wake of countless lobbying firms delisting Chinese clients as lawmakers have weighed blacklisting firms lobbying for the Chinese.
  • 171 bipartisan Members of the House sent a letter to Thompson and Scott in August of 2023 and 31 U.S.
  • Senators sent a similar letter to Senate Agriculture Chairman Debbie Stabenow, D-MI, and Ranking Member John Boozman, R-AR, last August.